Shannon M Delaney

Shannon M Delaney

UNVERIFIED PROFILE

Are you Shannon M Delaney?   Register this Author

Register author
Shannon M Delaney

Shannon M Delaney

Publications by authors named "Shannon M Delaney"

Are you Shannon M Delaney?   Register this Author

26Publications

575Reads

27Profile Views

Application of stem cell derived neuronal cells to evaluate neurotoxic chemotherapy.

Stem Cell Res 2017 07 15;22:79-88. Epub 2017 Jun 15.

Section of Hematology/Oncology, Department of Medicine, Chicago, IL, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2017.06.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737666PMC
July 2017

Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells.

PLoS One 2015 17;10(2):e0118020. Epub 2015 Feb 17.

Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0118020PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331516PMC
January 2016

Evaluation of inter-batch differences in stem-cell derived neurons.

Stem Cell Res 2016 Jan 31;16(1):140-8. Epub 2015 Dec 31.

Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL 60637, USA; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL 60637, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2015.12.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762730PMC
January 2016

Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy.

Clin Cancer Res 2015 Oct 26;21(19):4337-46. Epub 2015 May 26.

Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0133DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592389PMC
October 2015

Linking the genetic architecture of cytosine modifications with human complex traits.

Hum Mol Genet 2014 Nov 18;23(22):5893-905. Epub 2014 Jun 18.

Department of Pediatrics, Institute of Human Genetics, The University of Illinois, Chicago, IL 60612, USA,

View Article

Download full-text PDF

Source
https://academic.oup.com/hmg/article-lookup/doi/10.1093/hmg/
Publisher Site
http://dx.doi.org/10.1093/hmg/ddu313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204771PMC
November 2014

Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology Group.

Cancer Chemother Pharmacol 2014 Oct 14;74(4):831-8. Epub 2014 Aug 14.

Texas Children's Cancer Center, Baylor College of Medicine, 1102 Bates Ave., Suite 1570, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2535-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282931PMC
October 2014

Functional consequences of PRPF39 on distant genes and cisplatin sensitivity.

Hum Mol Genet 2012 Oct 5;21(19):4348-55. Epub 2012 Jul 5.

Department of Human Genetics, University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/dds266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441128PMC
October 2012

Whole-genome studies identify solute carrier transporters in cellular susceptibility to paclitaxel.

Pharmacogenet Genomics 2012 Jul;22(7):498-507

Section of Hematology/Oncology, Department of Medicine, University of Chicago Comprehensive Cancer, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e328352f436DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376193PMC
July 2012

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers.

Hum Mol Genet 2012 Apr 13;21(7):1470-80. Epub 2011 Dec 13.

Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddr583DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298275PMC
April 2012

Survival and tumorigenesis in O6-methylguanine DNA methyltransferase-deficient mice following cyclophosphamide exposure.

Mutagenesis 2008 Sep 13;23(5):341-6. Epub 2008 May 13.

Department of Pediatrics, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/mutage/gen018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527341PMC
September 2008

Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia.

Invest New Drugs 2008 Jun 24;26(3):233-9. Epub 2008 Jan 24.

Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center, 5841 S. Maryland Avenue, MC 2115, Chicago, IL 60637-1470, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-008-9115-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283497PMC
June 2008

Role of O6-methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice.

Carcinogenesis 2007 May 20;28(5):1111-6. Epub 2006 Nov 20.

Committee on Cancer Biology, The University of Chicago, 5841 S. Maryland Avenue, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgl218DOI Listing
May 2007

A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma.

Cancer Chemother Pharmacol 2006 Nov 7;58(5):634-9. Epub 2006 Mar 7.

Division of Hematology and Medical Oncology, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd. CR145, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-006-0210-0DOI Listing
November 2006

Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities.

J Pharmacol Exp Ther 2005 Dec 26;315(3):1247-55. Epub 2005 Aug 26.

Committee on Cancer Biology, The University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.105.083501DOI Listing
December 2005

Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanine.

Cancer Chemother Pharmacol 2005 Apr 2;55(4):333-342. Epub 2004 Oct 2.

Department of Medicine, Committee on Cancer Biology and Cancer Research Center, University of Chicago, Chicago, IL, 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-004-0901-3DOI Listing
April 2005

1,3- vs 1,5-intramolecular alkylation reactions in isophosphoramide and phosphoramide mustards.

Chem Res Toxicol 2004 Sep;17(9):1217-26

Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/tx030051kDOI Listing
September 2004

Enhancement of platinum-induced cytotoxicity by O6-benzylguanine.

Mol Cancer Ther 2003 Jul;2(7):633-40

Department of Medicine, Committee on Cancer Biology and Cancer Research Center, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
July 2003